Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave a path for new markets and technologies.
00:34 – How much of Carl Zeiss is ophthalmology?
01:00 – In ophthalmology we try to provide everything needed for diagnosis and treatment.
01:30 – The three parts of Zeiss
01:55- How have you seen the ophthalmology sector change?
02:45 – Are you acquiring start-ups?
03:10 – It really starts with working with surgeons and ophthalmologists.
04:04 – How is the Legacy of Zeiss a help and a hindrance?
05:10 – Zeiss benefits from a really strong brand.
05:25 – What other areas of ophthalmology will you target?
06:39 – How do Zeiss European roots help?
Ludwin Monz, PhD
Dr. Ludwin Monz has been President and CEO of Carl Zeiss Meditec AG since 2010 and was appointed a member of the Executive Board of the ZEISS group in 2014. Carl Zeiss Meditec is the medical technology company of the ZEISS group.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.